Health
Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2? – News-Medical.Net
A team of scientists from the USA recently developed a recombinant “Angiotensin converting enzyme 2 (ACE2) Triple Decoy” that can trap SARS-CoV-2 and prevent its…
A team of scientists from the USA recently developed a recombinant “Angiotensin converting enzyme 2 (ACE2) Triple Decoy” that can trap severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent its propagation inside the host cell. They have reported that the decoy has high affinity for different mutants of the spike receptor-binding domain (RBD) known to significantly increase viral transmission. The study is currently available on the bioRxiv* preprint server.
Background
Since its…
-
General7 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General23 hours agoFederal government funding extends cohealth GP services until July 2026
-
General10 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News22 hours agoFree flow of information vital to WHS – Proctor